Liz Shea

Head of Investor Relations

Equibles does not estimate personal net worth.

Get an email with a short summary when AbbVie Inc. publishes a filing, an earnings call transcript or a press release.

About Liz Shea

Liz Shea is recorded as Head of Investor Relations at AbbVie Inc. (ABBV). Liz Shea has spoken on 19 earnings calls and 1 other investor event across 1 company, most recently for AbbVie Inc. on June 22, 2026. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Robert A. Michael (CEO, Chairman, CFO, COO and Board Member), Richard A. Gonzalez (Chairman), Scott T. Reents (CFO) and 5 others.

Liz Shea on recent calls

“Good morning, and thank you for joining us for this special conference call to discuss AbbVie's acquisition of Apogee Therapeutics, which we announced earlier today.”

Head of Investor Relations, AbbVie Apogee Acquisition Conference Call · June 22, 2026

“Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer, Jeff Stewart, Executive Vice President, Chief Commercial Officer, Rupal Thakkar, Executive Vice President, Research and Development and Chief Financial Officer, and Scott Runtz, Executive Vice President, Chief Financial Officer.”

Head of Investor Relations, AbbVie Inc. Q1 FY2026 Earnings Call · April 29, 2026

“Also on the call with me today are Rob Michael, Chairman and Chief Executive Officer, Jeff Stewart, Executive Vice President, Chief Commercial Officer, Rupal Thakkar, Executive Vice President, Research and Development, Chief Scientific Officer, and Scott Rents, Executive Vice President, Chief Financial Officer.”

Head of Investor Relations, AbbVie Inc. Q4 FY2025 Earnings Call · February 4, 2026

“Also on the call with me today are Rob Michael, Chief Executive Officer Jeff Stewart, Executive Vice President, Chief Commercial Officer Roopal Thakkar, Executive Vice President, Research and Development, Chief Scientific Officer and Scott Reents, Executive Vice President, Chief Financial Officer.”

Head of Investor Relations, AbbVie Inc. Q1 FY2025 Earnings Call · April 25, 2025

“Also on the call with me today are Rob Michael, Chief Executive Officer; Jeff Stewart, Executive Vice President, Chief Commercial Officer; Roopal Thakkar, Executive Vice President, Research & Development, Chief Scientific Officer; Scott Reents, Executive Vice President, Chief Financial Officer; and Carrie Strom…”

Head of Investor Relations, AbbVie Inc. Q4 FY2024 Earnings Call · January 31, 2025